Cargando…
Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes
BACKGROUND: Sodium-glucose co-transporter 2 inhibitors have been shown to reduce body weight. However, little is known about whether a reduction in body weight affects glycemic and non-glycemic parameters. OBJECTIVES: The aim of this study was to investigate the link between the changes in body weig...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114207/ https://www.ncbi.nlm.nih.gov/pubmed/27798769 http://dx.doi.org/10.1007/s40268-016-0149-5 |